Best of the Week
Most Popular
1. Market Decline Will Lead To Pension Collapse, USD Devaluation, And NWO - Raymond_Matison
2.Uber’s Nightmare Has Just Started - Stephen_McBride
3.Stock Market Crash Black Swan Event Set Up Sept 12th? - Brad_Gudgeon
4.GDow Stock Market Trend Forecast Update - Nadeem_Walayat
5.Gold Significant Correction Has Started - Clive_Maund
6.British Pound GBP vs Brexit Chaos Timeline - Nadeem_Walayat
7.Cameco Crash, Uranium Sector Won’t Catch a break - Richard_Mills
8.Recession 2020 Forecast : The New Risks & New Profits Of A Grand Experiment - Dan_Amerman
9.Gold When Global Insanity Prevails - Michael Ballanger
10.UK General Election Forecast 2019 - Betting Market Odds - Nadeem_Walayat
Last 7 days
What happens To The Global Economy If Oil Collapses Below $40 – Part II - 15th Nov 19
America’s Exceptionalism’s Non-intervention Slide to Conquest, Empire - and Socialism - 15th Nov 19
Five Gold Charts to Contemplate as We Prepare for the New Year - 15th Nov 19
Best Gaming CPU Nov 2019 - Budget, Mid and High End PC System Processors - 15th Nov 19
Lend Money Without A Credit Check — Is That Possible? - 15th Nov 19
Gold and Silver Capitulation Time - 14th Nov 19
The Case for a Silver Price Rally - 14th Nov 19
What Happens To The Global Economy If the Oil Price Collapses Below $40 - 14th Nov 19
7 days of Free FX + Crypto Forecasts -- Join in - 14th Nov 19
How to Use Price Cycles and Profit as a Swing Trader – SPX, Bonds, Gold, Nat Gas - 13th Nov 19
Morrisons Throwing Thousands of Bonus More Points at Big Spend Shoppers - JACKPOT! - 13th Nov 19
What to Do NOW in Case of a Future Banking System Breakdown - 13th Nov 19
Why China is likely to remain the ‘world’s factory’ for some time to come - 13th Nov 19
Gold Price Breaks Down, Waving Good-bye to the 2019 Rally - 12th Nov 19
Fed Can't See the Bubbles Through the Lather - 12th Nov 19
Double 11 Record Sales Signal Strength of Chinese Consumption - 12th Nov 19
Welcome to the Zombie-land Of Oil, Gold and Stocks Investing – Part II - 12th Nov 19
Gold Retest Coming - 12th Nov 19
New Evidence Futures Markets Are Built for Manipulation - 12th Nov 19
Next 5 Year Future Proof Gaming PC Build Spec November 2019 - Ryzen 9 3900x, RTX 2080Ti... - 12th Nov 19
Gold and Silver - The Two Horsemen - 11th Nov 19
Towards a Diverging BRIC Future - 11th Nov 19
Welcome to the Zombie-land Of Stock Market Investing - 11th Nov 19
Illiquidity & Gold And Silver In The End Game - 11th Nov 19
Key Things You Need to Know When Starting a Business - 11th Nov 19
Stock Market Cycles Peaking - 11th Nov 19
Avoid Emotional Investing in Cryptocurrency - 11th Nov 19
Australian Lithium Mines NOT Viable at Current Prices - 10th Nov 19
The 10 Highest Paying Jobs In Oil & Gas - 10th Nov 19
World's Major Gold Miners Target Copper Porphyries - 10th Nov 19
AMAZON NOVEMBER 2019 BARGAIN PRICES - WD My Book 8TB External Drive for £126 - 10th Nov 19
Gold & Silver to Head Dramatically Higher, Mirroring Palladium - 9th Nov 19
How Do YOU Know the Direction of a Market's Larger Trend? - 9th Nov 19
BEST Amazon SMART Scale To Aid Weight Loss for Christmas 2019 - 9th Nov 19
Why Every Investor Should Invest in Water - 8th Nov 19
Wait… Was That a Bullish Silver Reversal? - 8th Nov 19
Gold, Silver and Copper The 3 Metallic Amigos and the Macro Message - 8th Nov 19
Is China locking up Indonesian Nickel? - 8th Nov 19

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Friday, July 24, 2015

Don’t Be Fooled by the “Quiet Season” for Biotech Stocks / Companies / BioTech

By: EWI

Marc Lichtenfeld writes: My favorite time to work is on weekend mornings before the rest of the house gets up.

I wake up, quietly go down the stairs and turn on the computer. While I’m waiting for it to boot up, I enjoy the peaceful scenery of the marsh outside my living room window. There are always amazing birds out there like sandhill cranes and egrets that are just a few feet from my window.

Read full article... Read full article...

 


Companies

Sunday, July 19, 2015

BSS Life Sciences Biotech Stock Analysis / Companies / BioTech

By: Richard_Mills

An endoscope is the medical device used - by direct insertion - to visualize suspicious masses in the hollow organs of the body such as the gastrointestinal tract, esophagus, lungs, urinary tract and uterus.

In 1805, Philip Bozzini used a rudimentary, light-guiding tube he created (a Lichtleiter - light guiding instrument) to view the urinary tract, pharynx, and rectum.

Read full article... Read full article...

 


Companies

Friday, July 03, 2015

The Biotech Market Is on Fire / Companies / BioTech

By: ...

MoneyMorning.com Spending on drugs here in the United States increased 13% last year to $374 billion – the single-biggest one-year jump in history. That’s a record-setting 4.3 billion prescriptions filled.

That means spending on drugs is rising at a rate that’s five times faster than the growth of the overall economy.

Read full article... Read full article...

 


Companies

Friday, June 19, 2015

These Promising Cancer Therapies Are a Biotech Stocks "Triple Play" / Companies / BioTech

By: ...

MoneyMorning.com Ernie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company's stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.

Over the months since June 2013, when Clovis Oncology Inc. (NASDAQ: CLVS) released positive trial data for both a lung cancer and a lymphoma drug, CLVS share value has soared 255%.

Read full article... Read full article...

 


Companies

Wednesday, June 17, 2015

Capitalize on Comeback Stories in Micro-Cap Biotech Stocks / Companies / BioTech

By: TLSReport

The list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors can find gems. Joseph Pantginis of ROTH Capital Partners recognizes the characteristics that make some of these tiny companies move up the ladder in market valuation. In this interview with The Life Sciences Report, Pantginis discusses five names with development programs capable of generating dramatic growth.

Read full article... Read full article...

 


Companies

Thursday, May 14, 2015

Ekso Stocks Set to Conquer the Most Valuable Unstoppable Trend of All / Companies / BioTech

By: ...

MoneyMorning.com Keith Fitz-Gerald writes: Most investors consider themselves fortunate to latch on to one really big trend in their investing lifetime. But imagine what happens when you latch on to two, three, or even four…

… at the same time, with the same investment!

That’s the situation we’ve got right now with one of my favorite Total Wealth recommendations.

Read full article... Read full article...

 


Companies

Thursday, May 14, 2015

Fire Up the Immune System to Fight Cancers and Boost Stocks Portfolios / Companies / BioTech

By: TLSReport

An immunotherapy revolution is rocking biotechnology, and investors are searching for just the right way to play the new trend. Do you go with an unknown company where the upside could be unparalleled? Do you go with an older name that has established partnerships with major pharmas? John McCamant, editor of the Medical Technology Stock Letter, has performed some serious diligence, and tells The Life Sciences Report about a handful of names with a range of market caps and the potential to achieve significant investment upside.

The Life Sciences Report: You're quite well aware that investors are looking hard at immunotherapeutics in oncology today. Do you think these initiatives to employ cellular and humoral responses in cancer therapies could be the final frontier, to use a dramatic term?

Read full article... Read full article...

 


Companies

Friday, April 17, 2015

How to Profit from Australia's Healthiest Biotech Stocks / Companies / BioTech

By: TLSReport

Australia will always be known as a trove of natural resources, but its most precious treasure is the abundance of entrepreneurs who are all too happy to develop the country's intellectual assets. Shane Storey, head of research at Australia-based Wilson HTM Investment Group, observes that as the market value of resource commodities declines, investors are diverting investment capital to healthcare stocks, especially in the medical technology sector. In this interview with The Life Sciences Report, Storey presents three names that don't come close to their long-term fair valuation potential. The upside, he believes, could be quite dramatic.

Read full article... Read full article...

 


Companies

Friday, April 03, 2015

Fat Loss Pills - How to Profit from America's $20 Billion Waistline War / Companies / BioTech

By: Money_Morning

Ernie Tremblay writes: Weight loss is a $20 billion per year industry. Yet, it seems the more we spend on shedding pounds, the more pounds we have to shed. Today, two-thirds of adults and one-third of children in the U.S. are overweight or obese, and the numbers are climbing.

With a growing market of that magnitude and so much money changing hands, it's no wonder investors' eyes light up when they hear the words "new obesity drug."

Read full article... Read full article...

 


Companies

Wednesday, March 11, 2015

Biotech Stocks Blowoff Beats Even Dot-Com Madness / Companies / BioTech

By: Anthony_Alfidi

Annual health tech fests like the JPMorgan Health Care Conference, Biotech Showcase, and One Med Forum came and went this year in San Francisco.  The star performers in this sector no doubt have a lot to brag about.  They will also have a lot of explaining to do when the biotech and health care sectors eventually crash.

Read full article... Read full article...

 


Companies

Saturday, February 21, 2015

The Seven Financial Indicators of Highly Successful Biotech Stocks Investing / Companies / BioTech

By: Money_Morning

Ernie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don't apply.

Here's why they don't, and why seven of these critical financial indicators do…

Read full article... Read full article...

 


Companies

Wednesday, December 31, 2014

Will Biotech Stocks Sector Fire on All Cylinders in 2015? / Companies / BioTech

By: TLSReport

Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication. The biotech market enjoyed a stellar 2013 and withstood a solid check in early 2014 before rebounding, essentially following the upward trend that most experts forecast. What is in store for 2015? The Life Sciences Report turned to newsletter writer John McCamant and WBB Securities' Steve Brozak for insight.

Read full article... Read full article...

 


Companies

Thursday, December 11, 2014

Genetic Cures for Disease: Impossible Biotech Dream Come True? / Companies / BioTech

By: TLSReport

Clinicians like to speak in terms of "managing" disease. That term of art is an admission that, in most cases, they can't cure the serious problems confronting patients. In this interview with The Life Sciences Report, David Nierengarten of Wedbush Securities explores gene therapies that actually correct an inborn mutation in human DNA, creating permanent change, actual cures and better lives for patients. It sounds beyond the reach of medicine . . . and therein lies the opportunity: Investors in gene therapy companies may capture serious returns on risk capital when the cure is attained.

Read full article... Read full article...

 


Companies

Tuesday, December 02, 2014

Bio-Tech Stock That Will Profit from a New Breakthrough Medical Direction / Companies / BioTech

By: Money_Morning

Ernie Tremblay writes: Modern medicine, for all of its sophisticated drugs, complex gadgets, and amazing surgical procedures, rarely cures anything. It treats. It manages. It postpones the inevitable.

But return a patient to normal, optimal health?

Read full article... Read full article...

 


Companies

Friday, November 21, 2014

Two Biotech Stocks Set to Double on One Powerful Catalyst / Companies / BioTech

By: Money_Morning

William Patalon writes: When I earned my MBA from the Rochester Institute of Technology (RIT) back in the mid-1990s, my focus was finance and investing.

But it was a management professor who clued me in to some of the best ways to "look past the numbers" and understand what really makes a big company tick.

The professor, Janet C. Barnard, retired a few years back and, sadly, passed away in 2012.

Read full article... Read full article...

 


Companies

Friday, October 24, 2014

Natus Medical Justifies Recent Run With Record Q3 Results / Companies / BioTech

By: Submissions

Nicholas Maithya writes: Natus Medical (NASDAQ:BABY) is up more than 125% over the last twelve months and based on recent results, that run seems fully justified with room left for more. The stock closed at $33.51 on Thursday 23, up 2.16% for the day following its impressive results released on the previous day.

Read full article... Read full article...

 


Companies

Thursday, October 23, 2014

Japan Gives a Hug to the Cell Therapy Biotech Industry / Companies / BioTech

By: TLSReport

Last year, Japan rolled out the red carpet for cell therapy developers with new legislation designed to expedite development of regenerative medicine solutions for all manner of disease. In this interview with The Life Sciences Report, former regenerative medicine consultant R. Lee Buckler, now a vice president with RepliCel Life Sciences Inc., puts his consultant's hat back on to talk about Japan's hospitable stance on proposed cell therapies. He provides an update on the meaning of the new law and discusses a small cohort of companies poised to reap the advantages.

Read full article... Read full article...

 


Companies

Wednesday, October 22, 2014

Follow the Baby Boom to Biotech Stock Profits / Companies / BioTech

By: TLSReport

In recent years, entrepreneurial therapists have comprised the fast-growing sector in outpatient physical therapy. But companies like Agility Health are beginning to seize acquisition opportunities and market share in this growing sector. Steven Davidson, CEO of Agility Health Inc., tells The Life Sciences Report how his company is innovating in the physical therapy space, improving patient care and clients' bottom lines through its management expertise and proprietary software, AgileRPM. With baby boomers aging and the Affordable Care Act increasing access to services, physical therapy just might be the safe haven sector to shield your portfolio from macroeconomic uncertainty.

Read full article... Read full article...

 


Companies

Friday, September 12, 2014

Apple’s Smartwatch May put Biotech on Silicon Valley Time / Companies / BioTech

By: John_Mauldin

By Patrick Cox

Tech sites are buzzing right now about the new Apple smartwatch and iPhone. Having been a part of or close to the tech industry for a long time, the excitement that builds over new products doesn’t normally move me much. This time, though, it’s a little different because of reports that the phone and watch will be integrated to support healthcare apps.

Read full article... Read full article...

 


Companies

Saturday, August 23, 2014

Oxaloacetate Feeds and GROWS Brain Cells - Alzheimers Cure? / Companies / BioTech

By: John_Mauldin

By Patrick Cox

Oxford Paper Shows Oxaloacetate Feeds and Grows Brain Cells

The headline above is good news for those of us who want to proactively protect our health and extend our lives. I remain pretty cynical about the vast majority of supplements that claim life-extension benefits, but this compound is one of the rare exceptions. Before describing this important paper, published by in the Oxford journal Human Molecular Genetics, let me explain a bit about oxaloacetate, which John Mauldin and I both take several times a day.

Read full article... Read full article...

 


Page << | 1 | 2 | 3 | 4 | 5 | 6 | >>